Anlotinib Retrospective Study for Esophageal Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Anlotinib
Related studies linked through entity extraction aliases.
Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC
- Status
- RECRUITING
- Phase
- PHASE2
Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.
- Status
- COMPLETED
- Phase
- PHASE2
Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
TAS-102 and Anlotinib in ≥3 Lines mGC
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1
- Status
- UNKNOWN
- Phase
- PHASE2
Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003
- Status
- UNKNOWN
- Phase
- PHASE2
Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE1
Anlotinib for Esophageal Cancer (AFEC)
- Status
- UNKNOWN
- Phase
- N/A
Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2